Shuxuetong injection and its peptides enhance angiogenesis after hindlimb ischemia by activating the MYPT1/LIMK1/Cofilin pathway
Preclinical pharmacology published in J Ethnopharmacol (2022)
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Shuxuetong (SXT) injection is formulated by leech and earthworm, has been widely used in the treatment of thrombotic cardiovascular and cerebrovascular diseases with remarkable clinical efficacy. AIM OF THE STUDY: The purpose of this study is to investigate the protective mechanism of SXT injection on the mice model of hindlimb ischemia, and to evaluate the angiogenic effects of SXT injection and its main active substances. MATERIALS AND METHODS: Hindlimb ischemia was induced by left femoral artery ligation. After operation, the mice were injected with saline, 10 mg/kg/d cilostazol, 37.5 mg/kg/d SXT injection, 75 mg/kg/d SXT injection and 150 mg/kg/d SXT injection via tail vein for 4 weeks. Ischemia severity was assessed using laser Doppler perfusion imaging system. Tissue recovery and capillary density were evaluated by histological and immunofluorescent staining. Vascular endothelial growth factor-A (VEGF-A) and platelet-derived growth factor (PDGF-BB) expression were measured by reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) analyses. Human umbilical vein endothelial cells (HUVECs) proliferation was measured using a BrdU kit and the viability of HUVECs was performed by MTT assay. Migration of HUVECs was performed by the wound healing method and a modified transwell assay. Capillary tube formation by HUVECs was examined by using Matrigel assay. Western blotting was used to detect the expressions of p-Cofilin, p-MYPT1, and p-LIMK1. RESULTS: SXT injection treatment significantly restored the blood flow and reduced tissue injury in mouse gastrocnemius muscle. SXT injection treatment increased capillary density and promoted angiogenesis in hindlimb ischemia. Moreover, SXT injection enhanced the expression of VEGF-A and PDGF-BB at both mRNA and protein levels in ischemic tissue of mice. SXT injection and its main active peptides dramatically increased the migration and capillary tube formation of HUVECs. SXT injection and its peptides enhanced protein expressions of the phosphorylation of MYPT1, Cofilin, and LIMK1. DSYVGDEAQSKR, YNELRVAPEEHP, and IQFLPEGSPVTM may act as the active components of SXT injection. CONCLUSION: SXT injection promoted angiogenesis and improved function recovery in hindlimb ischemia mice by regulation of VEGF-A/PDGF-BB. Moreover, SXT injection and its active peptides induced cell migration and tube formation in HUVECs through activating the MYPT1/LIMK1/Cofilin pathway. This study provided experimental basis for SXT injection in the treatment of ischemic diseases and revealed the effective substance of SXT injection in regulating angiogenesis, providing better evidence for the clinical application of SXT injection.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Резюме
Shuxuetong (a leech + earthworm injection) and its active peptides DSYVGDEAQSKR, YNELRVAPEEHP, and IQFLPEGSPVTM significantly restored blood flow in mouse hindlimb ischemia by activating MYPT1/LIMK1/Cofilin and increasing VEGF-A/PDGF-BB.
Почему это важно для гирудотерапии
Данное исследование изучало инъекционный препарат Шусюэтун (SXT) — лекарственную форму традиционной китайской медицины, содержащую пиявку и дождевого червя, — на модели ишемии задней конечности мыши и в культуре эндотелиальных клеток пупочной вены человека (HUVEC). Инъекция SXT достоверно восстанавливала кровоток, уменьшала повреждение тканей, увеличивала плотность капилляров и повышала экспрессию VEGF-A и PDGF-BB в ишемизированной ткани. В HUVEC препарат SXT и идентифицированные в нём пептиды (DSYVGDEAQSKR, YNELRVAPEEHP, IQFLPEGSPVTM) усиливали миграцию и тубулогенез посредством активации сигнального пути MYPT1/LIMK1/Cofilin. Это относится к области ASH, поскольку исследуется содержащий пиявку препарат с проангиогенным действием. Однако в исследовании применяется переработанная многокомпонентная инъекционная лекарственная форма, а не терапия живыми пиявками или очищенный секретом пиявки, и специфический вклад пиявочного компонента по сравнению с компонентом дождевого червя не может быть выделен из представленных данных.
Цитирование
Shuxuetong injection and its peptides enhance angiogenesis after hindlimb ischemia by activating the MYPT1/LIMK1/Cofilin pathway.
Sun W et al. · Journal of ethnopharmacology, 2022
Связанный клинический контекст
Узнайте, как это исследование связано с клинической практикой
Добавлено в библиотеку ASH: May 26, 2026 · Последнее обновление сайта: 18 июня 2026 г.